EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products

Christian Bailly iD

Life · 21.10.2025 · 15 (10) · 1638

DOI: 10.3390/life15101638 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 21.10.2025. Verfasst von Christian Bailly. Beteiligte Einrichtung: Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, 59000 Lille, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Highly degraded sterols belonging to the incisterol group have been identified in a large set of microorganisms. The leading product in the family is demethylincisterol A3 (DM-A3), isolated from various fungi and endowed with marked antitumor properties. Since the initial discovery of incisterol from a marine sponge in the 1990s, more than 30 incisterol-type natural products have been identified, essentially from fungi. An overview of these products, their bio-origin, chemical synthesis, and associated pharmacological properties is presented. The series includes diverse incisterol and demethylincisterol derivatives, chaxines, volemolide, different analogues (salimyxins, phellinignincisterols, daedatrin D, inonotoide F, aplykurodinone-1, dendrodoristerol), and a glycoside derivative (xyloneside), all bearing a tetracyclic incisterol framework. An analysis of the anticancer mechanism of the action of DM-A3 underlined the three main components of its activity associated with the (i) inhibition of β-catenin and the Wnt signaling pathway, (ii) inhibition of tyrosine phosphatase SHP2 (IC50 = 6.75 µM) implicated in cancer cell survival and differentiation, and (iii) blockade of α7nAchR activation coupled with inhibition of acetylcholinesterase (IC50 = 11.16 µM). A comprehensive picture of the DM-A3 mechanism of action is discussed, highlighting the uniqueness of the compound as a dual SHP2/AchE inhibitor able to attenuate an inflammatory response through the cholinergic anti-inflammatory pathway. The review shed light on this little-known category of incisterol-type natural products, with the objective of promoting further research into this neglected group of anticancer agents.

Schlagwörter

Stichwörter der Autor:innen

anticancerdegraded steroidsdemethylincisterol A3fungiincisterolvolemolide

Autor:innen und Institutionen

  • Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, 59000 Lille, France.
  • UMR9020-U1277-CANTHER-Cancer Heterogeneity Plasticity and Resistance to Therapies, CHU Lille, CNRS, Inserm, OncoLille Institute, University of Lille, 59000 Lille, France.
  • OncoWitan, Scientific Consulting Office, 59290 Lille, France.

ORCID-Profile: Christian Bailly

Zitieren

APA

Bailly, C. (2025). Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products. Life, 15(10), 1638. https://doi.org/10.3390/life15101638

Vancouver

Bailly C. Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products. Life. 2025;15(10):1638. doi:10.3390/life15101638

BibTeX
@article{Bailly2025,
  author = {Bailly, Christian},
  title = {Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products},
  journal = {Life},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1638},
  doi = {10.3390/life15101638}
}
Kostenlos starten →